The Comparison of EBUS-TBNA, TBMC Via a Tunnel, and TBFB Via a Tunnel in Diagnosing Mediastinal Lymphadenopathy.
- Conditions
- Lymphadenopathy HilarLymphadenopathy Mediastinal
- Registration Number
- NCT06262620
- Lead Sponsor
- China-Japan Friendship Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria:<br><br> - Age = 18 years;<br><br> - At least 1 hilar/mediastinal lesion (short axis = 1 cm) requiring diagnostic<br> bronchoscopy procedure;<br><br> - Patients who can understand the purpose of the trial, participate voluntarily and<br> sign an informed consent form.<br><br>Exclusion Criteria:<br><br> - The lesion is a mediastinal cyst or abscess;<br><br> - Combined severe cardiopulmonary diseases, coagulation disorders, poor tolerance to<br> anaesthesia, combined psychiatric disorders or severe neurosis and other relevant<br> contraindications to bronchoscopy;<br><br> - EBUS assessment reveals that the lesion is rich in blood flow or adjacent to a large<br> vessel, etc. Consider biopsy to be high risk and inappropriate for continuation of<br> biopsy;<br><br> - EBUS did not detect lesions in the hilum and/or mediastinum;<br><br> - Those who, in the judgement of the investigator, have poor patient compliance and<br> are unable to complete the study as required due to mental disorders, etc.
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dignostic yield of EBUS-TBNA, EBUS-TBMC via a tunnel, and EBUS-TBFB;Incidence rate of adverse events;the adequacy of sample acquisition
- Secondary Outcome Measures
Name Time Method the adequacy of sample acquisition